Literature DB >> 7988555

Reconstitution and transphosphorylation of TGF-beta receptor complexes.

F Ventura1, J Doody, F Liu, J L Wrana, J Massagué.   

Abstract

Transforming growth factor-beta (TGF-beta) signals by contacting two distantly related transmembrane serine/threonine kinases called receptors I (T beta R-I) and II (T beta R-II). TGF-beta binds to T beta R-II, which is a constitutively active kinase and this complex recruits T beta R-I, causing its phosphorylation and signal propagation to downstream substrates. The biochemical properties of this interaction were analyzed with reconstituted receptor systems. T beta R-I and T beta R-II baculovirally expressed at high levels in insect cells have the ligand binding properties of receptors expressed in mammalian cells, and form a complex in which T beta R-I phosphorylation is dependent on the kinase activity of T beta R-II. Furthermore, T beta R-I and T beta R-II can form a complex in vitro, and their cytoplasmic domains can specifically interact in a yeast two-hybrid system. In vitro complex formation with catalytically active T beta R-II is necessary and sufficient for T beta R-I phosphorylation, which within this complex does not require the catalytic activity of T beta R-I, thus mimicking T beta R-I phosphorylation in intact cells. In addition, T beta R-I phosphorylated in vitro remains associated with T beta R-II. These results suggest that T beta R-I and T beta R-II have affinity for each other, however, the ligand is required for stable complex formation under physiological conditions. Once formed, this complex is sufficient for T beta R-I phosphorylation by T beta R-II.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988555      PMCID: PMC395521          DOI: 10.1002/j.1460-2075.1994.tb06895.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases.

Authors:  H Y Lin; H F Lodish
Journal:  Trends Cell Biol       Date:  1993-01       Impact factor: 20.808

Review 2.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

3.  Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II.

Authors:  M Laiho; F M Weis; F T Boyd; R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

Review 4.  Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

Authors:  A B Roberts; M B Sporn
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

5.  The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand.

Authors:  A Moustakas; H Y Lin; Y I Henis; J Plamondon; M D O'Connor-McCourt; H F Lodish
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

6.  Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.

Authors:  P ten Dijke; H Ichijo; P Franzén; P Schulz; J Saras; H Toyoshima; C H Heldin; K Miyazono
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

7.  Characterization of type I receptors for transforming growth factor-beta and activin.

Authors:  P ten Dijke; H Yamashita; H Ichijo; P Franzén; M Laiho; K Miyazono; C H Heldin
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

8.  Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex.

Authors:  J L Wrana; H Tran; L Attisano; K Arora; S R Childs; J Massagué; M B O'Connor
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

9.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Authors:  A S Zervos; J Gyuris; R Brent
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  Cloning of a second type of activin receptor and functional characterization in Xenopus embryos.

Authors:  L S Mathews; W W Vale; C R Kintner
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

View more
  19 in total

1.  BMP-2 decreases Mash1 stability by increasing Id1 expression.

Authors:  Francesc Viñals; Julia Reiriz; Santiago Ambrosio; Ramon Bartrons; Jose Luis Rosa; Francesc Ventura
Journal:  EMBO J       Date:  2004-08-19       Impact factor: 11.598

2.  Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.

Authors:  J J Lebrun; W W Vale
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.

Authors:  X H Feng; R Derynck
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

4.  Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth.

Authors:  Roselyne Castonguay; Eric D Werner; Robert G Matthews; Eleonora Presman; Aaron W Mulivor; Nicolas Solban; Dianne Sako; R Scott Pearsall; Kathryn W Underwood; Jasbir Seehra; Ravindra Kumar; Asya V Grinberg
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

5.  A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein.

Authors:  Qian Tang; Cory M Staub; Guofeng Gao; Qunyan Jin; Zhengke Wang; Wei Ding; Rosemarie E Aurigemma; Kathleen M Mulder
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

6.  Activation of signalling by the activin receptor complex.

Authors:  L Attisano; J L Wrana; E Montalvo; J Massagué
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

7.  Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.

Authors:  K Luo; H F Lodish
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

8.  Mechanism of TGFbeta receptor inhibition by FKBP12.

Authors:  Y G Chen; F Liu; J Massague
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

9.  Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells.

Authors:  K Matsuzaki; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

10.  Requirement for protein kinase A in the phosphorylation of the TGFβ receptor-interacting protein km23-1 as a component of TGFβ downstream effects.

Authors:  Qunyan Jin; Yan Zhong; Kathleen M Mulder
Journal:  Exp Cell Res       Date:  2013-01-16       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.